Results 101 to 110 of about 5,312,533 (302)

IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer

Journal of Cellular and Molecular Medicine, 2020
Insulin‐like growth factor‐2 messenger RNA‐binding protein 3 (IGF2BP3) has been reported to contribute to tumorigenesis in several human cancers. However, the biological functions of IGF2BP3 in bladder cancer are poorly understood.
Wei Huang, Yuan-yuan Li, Cheng Zhang, Huihai Zha, Xiaochen Zhou, B. Fu, Ju Guo, Gongxian Wang   +7 more
semanticscholar   +1 more source

Bladder Cancer Carcinogens: Opportunities for Risk Reduction [PDF]

, 2023
Christopher Gaffney, Andrew Katims, Neeta D’Souza, Marc A. Bjurlin, Richard S. Matulewicz   +4 more
openalex   +1 more source

Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: assessing prognostic and predictive value in SWOG 8710 [PDF]

, 2017
No abstract ...
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration, Asano, Ferro, Gondo, Grenader, Guthrie, Krane, Linton, Lorente, Mitchell, Ojerholm, Templeton, Viers   +12 more
core   +1 more source

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2

Molecular Cancer, 2020
Accumulating evidence indicates that long non-coding RNAs (lncRNAs) are potential biomarkers and key regulators of tumour development and progression.
Y. Zhan, Zhicong Chen, Shi-ming He, Y. Gong, Anbang He, Yifan Li, Lianghao Zhang, Xuepei Zhang, D. Fang, Xuesong Li, Li-qun Zhou   +10 more
semanticscholar   +1 more source

Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.

Translational Oncology
Bladder cancer (BLCA) genomic profiling has identified molecular subtypes with distinct clinical characteristics and variable sensitivities to frontline therapy. BLCAs can be categorized into luminal or basal subtypes based on their gene expression.
Sharada Mokkapati, Ganiraju Manyam, Alexis R. Steinmetz, Côme Tholomier, Alberto Martini, Woonyoung Choi, Bogdon Czerniak, Byron H Lee, Colin P Dinney, David J McConkey   +9 more
doaj   +1 more source

Solitary Bladder Metastasis of Prostate Cancer Mimicking Bladder Submucosal Tumor: A Case Report

대한영상의학회지, 2017
Prostate cancer is one of the most common causes of secondary cancer to the bladder. There have been few reports about distant metastasis to the bladder from primary prostate cancer, since secondary involvement of the urinary bladder in prostate cancer ...
Doo Ri Kim, Jeong Sub Lee, Guk Myung Choi, Bong Soo Kim, Seung Hyoung Kim, Mu Sook Lee, Young-Joo Kim, Chang Lim Hyun   +7 more
doaj   +1 more source

Heterogeneity in the Relationship between Disinfection By-Products in Drinking Water and Cancer: A Systematic Review. [PDF]

, 2018
The epidemiological evidence demonstrating the effect of disinfection by-products (DBPs) from drinking water on colon and rectal cancers is well documented.
Benmarhnia, Tarik, Delpla, Ianis, Levallois, Patrick, Rodriguez, Manuel J, Schwarz, Lara   +4 more
core   +2 more sources

Biomarkers in bladder cancer

Histopathology, 2010
Proctor I, Stoeber K & Williams G H
(2010) Histopathology 57, 1–13
Biomarkers in bladder cancerCancer biomarkers provide an opportunity to diagnose tumours earlier and with greater accuracy. They can also identify those patients most at risk of disease recurrence and predict which tumours will respond to different therapeutic approaches.
Proctor, Ian, Stoeber, Kai, Williams, Gareth   +2 more
openaire   +3 more sources

Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer [PDF]

, 2015
Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum complementation group C (XPC) has been described in bladder cancer.
Boormans, J.L. (Joost), Brandsma, I. (Inger), Bruens, S.T. (Serena), Gent, D.C. (Dik) van, Hoeijmakers, J.H.J. (Jan), Jaspers, N.G.J. (Nicolaas), Kanaar, R. (Roland), Leenders, G.J.H.L. (Geert), Naipal, K.A.T. (Kishan A.T.), Pothof, J. (Joris), Raams, A. (Anja), Verkaik, N.S. (Nicole)   +11 more
core   +1 more source

Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway

Cancer Science, 2020
Luteolin is a natural flavonoid with strong anti–oxidative properties that is reported to have an anti–cancer effect in several malignancies other than bladder cancer. In this study, we describe the effect of luteolin on a human bladder cancer cell line,
K. Iida, T. Naiki, A. Naiki‐Ito, Shugo Suzuki, Hiroyuki Kato, S. Nozaki, T. Nagai, T. Etani, Y. Nagayasu, R. Ando, N. Kawai, T. Yasui, Satoru Takahashi   +12 more
semanticscholar   +1 more source